3653 results for «288»

Filter By

3653 results

Expanding the spectrum of TEER suitability

18 Feb 2023 – From PCR Tokyo Valves 2023

Join this session to delve into diverse Transcatheter Edge-to-Edge Repair (TEER) scenarios, covering optimal patient groups for MitraClip therapy, insights from the EXPAND G4 study and the meticulous choice of four clip sizes for varying valve anatomies.

Clinical cases - Structural interventions - Session 7

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 9

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

TAVI

18 Feb 2023 – From PCR Tokyo Valves 2023

Discover a selection of cases exploring TAVI at PCR Tokyo Valves 2023 in this session: long-term survival assessment after TAVI, cerebral embolic protection devices for stroke prevention, ultrasound-guided vs. conventional MANTA vascular closure devices, and more!

AICT-AsiaPCR 2023 Opening Ceremony

21 Sep 2023 – From AICT-AsiaPCR 2023

This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...

AICT-AsiaPCR 2023 Opening Ceremony

Percutaneous treatment of pure aortic regurgitation: a new indication

21 Sep 2023 – From AICT-AsiaPCR 2023

Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.

Percutaneous treatment of pure aortic regurgitation: a new indication

Valve-in-valve - LIVE case

21 Sep 2023 – From AICT-AsiaPCR 2023

An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.

A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).

Closure was...

Valve-in-valve- AICT-AsiaPCR 2023

RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

01 Sep 2024

While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!

Author

Chiara De Biase

Author

Helene Eltchaninoff
Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
RHEIA

Interventional management of an aortic root fistula after aortic-valve endocarditis

25 Jan 2021

This is a 44-year old male patient with an aortic root fistula to the right heart after past infective aortic valve endocarditis. Interventional shunt occlusion was successfully performed using a transcatheter closure device.

Interventional aortic root fistula closure

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 Aug 2024

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
Tri.fr trial
Didn’t find what you were looking for?